Prevenar 13 suspension for injection in single dose vial pneumococcal polysaccharide conjugate vaccine (13-valent

DRUG4 trials

Sponsors

Leiden University Medical Center, Novartis Pharma AG, Lillebaelt Hospital, Centre Hospitalier Universitaire De Poitiers

Conditions

Healthy volunteersLymphomaRelapsing multiple sclerosis (RMS)multiple myeloma

Phase 2

Optimisation of lymph node fine needle aspiration to study pneumococcal vaccine-induced immunity

RecruitingCTIS2022-501519-15-00

Leiden University Medical CenterHealthy volunteers

Start: 2023-04-01Target: 5Updated: 2024-06-20

Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICTORIA)

Active, not recruitingCTIS2024-512731-74-00

Lillebaelt Hospitalmultiple myeloma

Start: 2020-07-03Target: 50Updated: 2025-01-09

Phase 3

An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis (RMS)

Active, not recruitingCTIS2023-507906-15-00

Novartis Pharma AGRelapsing multiple sclerosis (RMS)

Start: 2019-01-30Target: 963Updated: 2025-11-14

Phase 4

HEMATOVAC-Immunogenicity of an Anti-pneumococcal Combined Vaccination (PCV13+PPV23 versus PREVENAR20) in Lymphoma

RecruitingCTIS2024-517288-22-01

Centre Hospitalier Universitaire De PoitiersLymphoma

Start: 2021-01-29Target: 160Updated: 2025-10-23